Attorney General Raoul Leads Coalition to Protect Patient Access to Preventative Health Care Services

Lawndale News Chicago's Bilingual Newspaper - Health

Attorney General Kwame Raoul led a coalition of 24 attorneys general in filing an amicus brief to protect a key provision of the Patient Protection and Affordable Care Act (ACA) that guarantees access to critical preventive care for millions of Americans. Congress enacted the ACA’s preventive services provision because, previously, many Americans struggled to afford preventive care, which can be lifesaving but was often not covered by insurance. The preventive services provision eliminated this financial barrier by requiring most private insurance plans to cover certain preventive services and treatments, such as cancer screenings and vaccinations, without charging out-of-pocket costs, including copayments or deductibles. The provision faces a legal challenge in Braidwood v. Becerra, filed by several individuals and employers who want to purchase or offer health insurance that does not cover certain preventive services, most notably contraceptive care and prophylactic HIV care. They argue that these requirements should be eliminated for various reasons, including that they violate individuals’ rights under the Religious Freedom Restoration Act (RFRA) and that the process for determining which services are covered under the provision violates the U.S. Constitution’s Appointments Clause. Raoul and the coalition filed their brief in support of the federal government in the 5th Circuit, which is resolving appeals by the federal government and the plaintiffs following the district court’s decision. The brief notes that many Americans have come to rely on the no-cost health care access provided by the provision. Within four years of the ACA’s passage, approximately 76 million Americans gained expanded coverage to one or more preventive services. As of 2020, an estimated 151.6 million people were enrolled in private insurance plans that cover preventive services at no cost to patients.

Comments are closed.